Press Releases

• Alessa Therapeutics: FDA Fast Track Designation for Enolen, A First-Of-Its-Kind Treatment for Localized Prostate Cancer More
• Allogene Therapeutics: Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T More
• ALX Oncology: Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004 More
• Ashvattha Therapeutics: Appoints Life Healthcare Veteran George Montgomery as Executive Chairman to Lead Corporate Development and Strategic Partnerships More
• Biocytogen and Acepodia: Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C) More
• DELFI Diagnostics: Appoints Cindy Soriano as Chief Financial Officer and Participation in 44th Annual J.P. Morgan Healthcare Conference More
• Encoded Therapeutics: Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference More
• Evidation: Launches Temporal Proteomics Platform to Power Multimodal Autoimmune Research Cohort More
• Factorial Biotechnologies and Honeycomb Biotechnologies: Partner to Deliver High-Throughput, Instrument-Free Single-Cell DNA Sequencing More
• Innovent Biologics: Partner Ollin Biosciences Announces Positive Topline Data With Superior Outcomes From a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration More
• Kezar Life Sciences: Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis More
• MapLight Therapeutics: Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 More
• Octave Bioscience: Expands Leadership Team With Appointment of Kirk Stockwood Senior Vice President, Commercial More
• Ossium Health: Peer-Reviewed Study Establishes Consistent Quality and Early Clinical Success of Ossium’s Proprietary Off-the-Shelf Bone Marrow More
• PacBio and UC Davis Researchers: Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies From a Single SMRT Cell More
• Pulse Biosciences: Inc. Appoints Maria Sainz to Its Board of Directors More
• Ray Therapeutics: Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors More
• Septerna: Expands Leadership With Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer More
• Tenaya Therapeutics: 2026 Strategic Priorities and Anticipated Milestones More
• Verana Health Merges With COTA to Dramatically Expand Scale, Velocity, and Depth of Real-World Data Offerings Across Oncology and Other Specialties More
• Visby: Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs More More

Financial News

• AirNexis Therapeutics: Launches With $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD) More More*
• Billionaire Sean Parker Has Already Shaken Up Cancer R&D. Can His Nonprofit Fix the Funding Gap? More
• Exclusive VC Funding Data from BYTE51, with Special Big4Bio Pricing More
• Exclusive: With New AI Deal, Eli Lilly and Chai Discovery Kick Off a ‘Year of Deployment’ in Pharma More*
• JPM Week Conference Readiness Packages (Big4Bio Subscriber Discount) More
• Merck in Talks to Buy Cancer Drugmaker Revolution Medicines for up to $32Bn More More* More*
• More on Day One Concluding Mersana Therapeutics Acquisition More
• More on EpiBiologics Raising $107M for Its Protein-Degrading Cancer Drug More More*
• More on GSK Inking a Model Deal in $50M Bet on Noetik’s Cancer AI Platform More More*
• More on Personalis 2025 Test Volume Surging as Prelim Full-Year Revenue Falls More*
• Orca Bio: $250M in Aggregate Financing in Preparation for Potential Commercialization More
• SonoThera: Launches $125M Series B at 44th J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs Toward First-in-Human Studies More
• Will Biotech’s Big JPM Conference Signal a New Normal for the Industry and San Francisco? More*

Media/Misc Coverage

• BioPharmGuy News: Website Archaeology, Magic Pills, Sickness is Health, Reverse Food Funnel More
• Former Head of Genentech Cancer-Fighting Unit Lands at German Biotech More*
  
• More on Gordian Bio Teaming Up With Pfizer to Advance In Vivo Target Discovery for Obesity More
  
• Subscribe to LifeSci Startup for Updates on US Startups More
• The Big4Bio Podcast: Biotech Showcase Readies as Biotech Stocks and Deals Pick Up Podcast
• The Big4Bio Podcast: Every Moment Matters: DMPK’s Role in Making Better Drugs and Better Decisions Podcast
• The Physics Mindset Behind One of Biotech’s Fastest-Growing Diagnostics Companies More

Companies

Career Center

• AI in Biotech: The New Frontier for Leadership & Strategy More
• How Industry Trends are Impacting Hiring Decisions and Leadership Strategies in Life Sciences More
• M&A in Life Sciences: The Turning Tide – Why Now is a Strategic Inflection for Biopharma and Biotech More
• ICYMI: CEO’s Perspective: Big Moves Come with Big Responsibility More
• ICYMI: CEO’s Perspective: The High Cost of Job Hopping More
• ICYMI: Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders More
• ICYMI: The Power of Peer Learning - Why Even Top Biotech Leaders Need Mentorship More
• ICYMI: What’s Next in Precision Medicine: Leadership Challenges and Opportunities More
• The Rise of Fractional Talent in Life Sciences: What to Expect in 2026 More

• BLPN Investor Summit Jan 8-10
• J.P. Morgan Healthcare Conference Jan 12-15
• ABD Capital Connect @ JPM Week 2026 Jan 12-13
  
• Biotech Showcase Jan 12-14
• Fierce JPM Week Jan 13-14
• PepTalk 2026 Jan 19-27
• SLAS2026 International Conference & Exhibition Feb 7-12
• IO360° Summit Feb 10-12

SF Bay Sponsors